What Makes a Life Sciences Company Worth Following?

When a life sciences company questions the effectiveness of its social media presence, the conversation often turns to its publishing calendar rather than the strategy behind it.

Publication announcements, conference participation, hiring updates, awareness campaigns, and executive commentary all have a place in a company's communications strategy. The challenge begins when these activities become the strategy itself, rather than supporting a defined business objective.

Publishing frequency alone does not establish relevance or credibility. For life sciences companies communicating with investors, clinicians, potential partners, and patient communities, the greater consideration is whether the content provides information or perspective that each audience finds valuable.

Start With the Audience, Not the Calendar

If someone doesn’t already know a company, would anything on their social media feed give them a reason to come back?

Many corporate feeds are dominated by organizational milestones. Conference participation, financing announcements, leadership appointments, and industry recognition can all communicate progress. However, without additional context explaining why those developments matter, companies risk speaking primarily about themselves rather than addressing the priorities of their audiences.

A valuable corporate presence offers more than updates. It provides informed perspectives on industry developments, applies scientific or commercial expertise to challenges audiences care about, and offers context around the decisions shaping a company's direction.

Build Recognition Around a Defined Area of Expertise

In life sciences, companies have opportunities to establish authority around specific areas of expertise, whether that involves a therapeutic mechanism, a patient population, a clinical development challenge, or the evolving commercial landscape within a particular disease area.

Consistent positioning helps audiences understand where a company contributes expertise and why its perspective is relevant. Over time, this creates stronger associations between the organization, its leadership, and the scientific or commercial topics it is qualified to address.

This is where well resourced programs often fall apart. They move across subjects week to week, following whatever the calendar produced, and the audience never accumulates. Every post starts from zero. A company publishing twice a month on the same territory for a year will end up with more influence than one publishing five times a week across nine unrelated ones.

Corporate Voice Is Built Through Consistency and Credibility

Corporate voice extends beyond writing style or brand guidelines. It reflects how an organization communicates its expertise, interprets industry developments, and maintains consistency across both positive announcements and more challenging periods.

Credibility is built over time, but can be challenged when communication becomes inconsistent. Clinical setbacks, regulatory developments, or changes in corporate priorities require thoughtful communication planning. While disclosure obligations and scientific accuracy must guide what can be shared, maintaining a clear and reliable voice is particularly important during periods of uncertainty.

Executive leadership plays an important role in establishing that credibility, particularly when corporate leaders contribute informed perspectives that complement the company's broader communications.

Executive thought leadership is most effective when leaders contribute perspectives grounded in their experience and expertise. A CEO who consistently addresses a relevant scientific, operational, or commercial challenge can establish a more recognizable point of view than one whose participation is limited to resharing corporate announcements.

What this looks like in practice

Begin by identifying the areas where the company has established expertise and a credible opportunity to contribute to industry conversations. These priorities should reflect the organization's scientific capabilities, business objectives, competitive positioning, and the information needs of its most important audiences.

From there, establish a focused set of editorial priorities that connect corporate milestones with the questions investors, clinicians, partners, and other stakeholders are asking. Evaluate each piece of content based on its purpose, audience relevance, and contribution to the company's overall positioning. Rather than reducing volume by default, assess whether the current publishing cadence allows the organization to maintain quality, consistency, and appropriate engagement.

From there, establish a focused set of editorial priorities that connect corporate milestones with the questions investors, clinicians, partners, and other stakeholders are asking. Evaluate each piece of content based on its purpose, audience relevance, and contribution to the company's overall positioning. Rather than reducing volume by default, assess whether the current publishing cadence allows the organization to maintain quality, consistency, and appropriate engagement.

Remove the duplicated final paragraphStrengthen the practical recommendations

‍